Predictive Risk Factors in Double-Valve Replacement (AVR and MVR) Compared to Isolated Aortic Valve Replacement[1]

Abstract

Background: The operative risk of combined aortic and mitral surgery is still between 5 and 13 %, whereas isolated AVR normally causes complications in less than 4 % of all patients. Thus, it was the aim of the study to compare both procedures and to evaluate risk stratification in our patient cohort. Patients and Methods: The inhospital mortality and complication rates were analyzed in both groups over a period of 4 years. There were 396 patients with isolated AVR, and 98 patients with AVR and MVR. For both groups, we investigated 16 possible risk factors for perioperative death or severe complications, such as low cardiac output syndrome (LCOS). The risk factors were analyzed by univariate analysis, and factors with p < 0.01 were entered into a multivariate analysis. Results: There were 11/396 perioperative deaths in patients with AVR (2.8 %) compared to 5/98 (5.1 %) in DVR. The incidence of major complications was 5.3 % in AVR vs. 11.2 % in DVR. As risk factors (p < 0.05) for death, we found in AVR: former cardiac surgery, aortic stenosis, and pulmonary arterial pressure > 55 mmHg. In patients with DVR, we additionally found: left atrial pressure (LAP) > 20 mmHg and creatinine > 2 mg/dl. Risk factors for severe complications in AVR were: former cardiac surgery and creatinine > 2 mg/dl, in cases of DVR, additionally: tricuspid valve disease (TVD) and LAP > 20 mmHg. Conclusions: Our analysis of risk factors shows that in patients with DVR preoperative parameters, which sometimes are estimated to be unimportant, may cause an adverse outcome. The operation should be carried out before reaching advanced or even end-stage heart failure, and more attention should be paid to an individual perioperative concept and optimized myocardial protection in such patients.

Aortic valve replacement - double-valve replacement - risk factor - regression analysis

References

• 1 Bortolotti U, Milano A, Testolini L, Trusi V, Mazzucco A, Gallucci V. Influence of type of prosthesis on late results after combined mitral-aortic valve replacement.  Ann Thorac Surg. 1995;  59 1113-1119
• 2 Munro A L, Jamieson E, Burr L H, Ling H, Miyagishima R T, Germann E. Comparison of porcine bioprostheses and mechanical prostheses in multiple valve replacement operations.  Ann Thorac Surg. 1995;  60 459-463
• 3 Khan S S, Trento A, DeRobertis M. Twenty-year comparison of tissue and mechanical valve replacement.  J Thorac Cardiovasc Surg. 2001;  122 257-269
• 4 Kuwaki K, Tsukamoto M, Komatsu K, Morishita K, Sakata J, Abe T. Simultaneous aortic and mitral valve replacement: predictors of adverse outcome.  J Heart Valve Dis. 2003;  12 169-176
• 5 Armenti F, Stephenson L W, Edmunds L H. Simultaneous implantation of St. Jude Medical aortic and mitral prostheses.  J Thorac Cardiovasc Surg. 1987;  94 733-739
• 6 Arom K V, Nicoloff D M, Kersten T E, Northrup W F, Lindsay W G, Emery R W. Ten-year follow-up study of patients who had double valve replacement with the St. Jude Medical prosthesis.  J Thorac Cardiovasc Surg. 1989;  98 1008-1016
• 7 Teoh K H, Christakis G T, Weisel R D. The determinants of mortality and morbidity after multiple-valve operations.  Ann Thorac Surg. 1987;  43 353-358
• 8 Fiore A C, Swartz M T, Sharp T. Double-valve replacement with Medtronic Hall or St. Jude valve.  Ann Thorac Surg. 1995;  59 1113-1119
• 9 Brown P S, Roberts C S, McIntosh C L, Swain J A, Clark R E. Relation between choice of prostheses and late outcome in double-valve replacement.  Ann Thorac Surg. 1993;  66 631-640
• 10 Caus T, Rouviere P, Clooart F, Mouly-Bandini A, Monties J R, Mesana T. Late results of double-valve replacement with biological or mechanical prostheses.  Ann Thorac Surg. 2001;  71 261-263
• 11 Galloway A C, Grossi E A, Baumann F G. et al . Multiple valve operation for advanced valvular heart disease: results and risk factors in 513 patients.  J Am Coll Cardiol. 1992;  19 725-732
• 12 Edmunds L H, Clark R E, Cohn L H, Grunkemeier G L, Miller C, Weisel R D. Guidelines for reporting morbidity and mortality after cardiac valvular operations.  Ann Thorac Surg. 1996;  62 932-935
• 13 Turina J, Stark T, Seifert B, Turina M. Predictors of the long-term outcome after combined aortic and mitral valve surgery.  Circul. 1999;  100 (Suppl 2) 48-53
• 14 Bebatz L F, Ruchat P, Hurni M. St. Jude Medical valve prosthesis: an analysis of long-term outcome and prognostic factors.  J Thorac Cardiovasc Surg. 1997;  113 134-148
• 15 Mueller X M, Tevaearai H T, Stumpe F. Long-term results of mitral-aortic valve operations.  J Thorac Cardiovasc Surg. 1998;  115 1298-1309
• 16 Simon R, Oelert H, Borst H G, Lichtlen P. Influence of mitral valve surgery on tricuspid incompetence concomitant with mitral valve disease.  Circul. 1980;  62 1152-1157
• 17 King R M, Schaff H V, Danielson G K, Gersh B J, Orszulak T A, Pichler J M, Puga F J, Pluth J R. Surgery for tricuspid regurgitation late after mitral valve replacement.  Circul. 1984;  70 (Suppl 2) 193-197
• 18 Cohn L H, Couper G S, Aranki S F, Rizzo R J, Kinchla N M, Collins J J. Long-term results of mitral valve reconstruction for regurgitation of the myxomatous mitral valve.  J Thorac Cardiovasc Surg. 1994;  107 143-151
• 19 Turina J, Milinic J, Seifert B, Turina M. Valve replacement in chronic aortic regurgitation: true predictors of survival after extended follow-up.  Circul. 1998;  98 (Suppl 2) 100-107
• 20 Nashef S A, Roques F, Michel P, Cortina J, Faichney A, Gams E, Harjula A, Jones M T. Coronary surgery in Europe: comparison of the national subsets of the european system for cardiac operative risk evaluation database.  Eur J Cardiothorac Surg. 2000;  17 396-399

1 The results of this paper were presented in part during the 34th annual meeting of the German Society of Thoracic- and Cardiovascular Surgery, February 13th - 16th, 2005 in Hamburg/Germany as poster presentation.